Synapse - Gynecologic Medicine Service

Results (2180)

Serous tubal intraepithelial carcinoma (STIC) at the time of primary debulking surgery (PDS) of high-grade serous ovarian cancer (HGSOC): Does it matter?

Meeting Abstract

Boerner, T.; Chi, A.; Zivanovic, O.; Soslow, R. A.; Sonoda, Y.; Gardner, G. J.; Leitao, M. M.; Tew, W. P.; Konner, J.; Grisham, R. N.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Population exposure-safety and exposure-efficacy analyses for rucaparib in patients (pts) with recurrent ovarian carcinoma (rOC) from Study 10 and ARIEL2

Meeting Abstract

Konecny, G. E.; Oza, A. M.; Tinker, A. V.; Oaknin, A.; Shapira-Frommer, R.; Ray-Coquard, I.; Aghajanian, C.; Coleman, R. L.; O'Malley, D. M.; Leary, A.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Frailty based on the Memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer

Meeting Abstract

Filippova, O. T.; Alonso, J.; Tin, A.; Vickers, A. J.; Tew, W. P.; Gardner, G. J.; Sonoda, Y.; Long Roche, K.; Zivanovic, O.; Chi, D. S.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Postprogression outcomes in patients with ovarian carcinoma associated with amutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3

Meeting Abstract

O'Malley, D. M.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Outcomes of newly diagnosed stage II ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab

Meeting Abstract

Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Optimizing number of preoperative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer

Meeting Abstract

Liu, Y. L.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; Konner, J.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma

Meeting Abstract

Basaran, D.; Sassine, D.; Brandt, B.; Mueller, J. J.; Broach, V.; Cadoo, K. A.; Soslow, R. A.; Alektiar, K.; Abu-Rustum, N. R.; Leitao, M. M. Jr
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Association of CD8+ T cell gene expression signatures with outcomes in the distinct molecular subtypes of endometrial cancer

Meeting Abstract

Dessources, K.; Ferrando, L.; Riaz, N.; Reis-Filho, J.; Zamarin, D.; Weigelt, B.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Exploring the relationship between homologous recombination score and progression-free survival in BRCA wildtype ovarian carcinoma: Analysis of veliparib plus carboplatin/paclitaxel in the velia study

Meeting Abstract

Swisher, E. M.; Kaufmann, S. H.; Birrer, M. J.; Levine, D. A.; Moore, K. N.; Fleming, G. F.; Coleman, R. L.; Bookman, M. A.; Timms, K. M.; Sullivan, D. M.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Anti-tumor activity of veliparib during combination phase with chemotherapy in velia study

Meeting Abstract

O'Malley, D. M.; Bookman, M. A.; Moore, K. N.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Aghajanian, C.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save